Efficacy and safety of telbivudine versus tenofovir treatment based on the Roadmap concept: Results from a randomized, controlled trial in HBeAg-negative chronic hepatitis B patients

Basit Öğe Kaydı
dc.contributor.authorKrastev, Zahary
dc.contributor.authorKotzev, Iskren A.
dc.contributor.authorCelen, Mustafa K.
dc.contributor.authorMc Neeley, David
dc.contributor.authorHamed, Kamal A.
dc.date.accessioned2024-04-24T17:48:08Z
dc.date.available2024-04-24T17:48:08Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- NOV 07-11, 2014 -- Boston, MAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage1104Aen_US
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.startpage1104Aen_US
dc.identifier.urihttps://hdl.handle.net/11468/22900
dc.identifier.volume60en_US
dc.identifier.wosWOS:000344483804440
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleEfficacy and safety of telbivudine versus tenofovir treatment based on the Roadmap concept: Results from a randomized, controlled trial in HBeAg-negative chronic hepatitis B patientsen_US
dc.titleEfficacy and safety of telbivudine versus tenofovir treatment based on the Roadmap concept: Results from a randomized, controlled trial in HBeAg-negative chronic hepatitis B patients
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu